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Abstract
The T cell receptor (TCR) repertoire is an essential component of the CD8 T-cell immune
response. Here, we seek to investigate factors that drive selection of TCR repertoires spe-
cific to the HLA-A2-restricted immunodominant epitope BRLF1109-117 (YVLDHLIVV) over
the course of primary Epstein Barr virus (EBV) infection. Using single-cell paired TCRαβ
sequencing of tetramer sorted CD8 T cells ex vivo, we show at the clonal level that recogni-
tion of the HLA-A2-restricted BRLF1 (YVL-BR, BRLF-1109) epitope is mainly driven by the
TCRα chain. For the first time, we identify a CDR3α (complementarity determining region 3
α) motif, KDTDKL, resulting from an obligate AV8.1-AJ34 pairing that was shared by all four
individuals studied. This observation coupled with the fact that this public AV8.1-KDTDKL-
AJ34 TCR pairs with multiple different TCRβ chains within the same donor (median 4;
range: 1–9), suggests that there are some unique structural features of the interaction
between the YVL-BR/MHC and the AV8.1-KDTDKL-AJ34 TCR that leads to this high level
of selection. Newly developed TCR motif algorithms identified a lysine at position 1 of the
CDR3α motif that is highly conserved and likely important for antigen recognition. Crystal
structure analysis of the YVL-BR/HLA-A2 complex revealed that the MHC-bound peptide
bulges at position 4, exposing a negatively charged aspartic acid that may interact with the
positively charged lysine of CDR3α. TCR cloning and site-directed mutagenesis of the
CDR3α lysine ablated YVL-BR-tetramer staining and substantially reduced CD69 upregula-
tion on TCR mutant-transduced cells following antigen-specific stimulation. Reduced activa-
tion of T cells expressing this CDR3 motif was also observed following exposure to mutated
(D4A) peptide. In summary, we show that a highly public TCR repertoire to an immunodomi-
nant epitope of a common human virus is almost completely selected on the basis of
CDR3α and provide a likely structural basis for the selection. These studies emphasize the
importance of examining TCRα, as well as TCRβ, in understanding the CD8 T cell receptor
repertoire.
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Author summary
EBV is a ubiquitous human virus that has been linked to several diseases, including can-
cers and post-transplant lymphoproliferative disorders. CD8 T cells are important for
controlling EBV replication. Generation and maintenance of virus-specific CD8 T cells is
dependent on specific interaction between MHC-peptide complexes on the infected cell
and the TCR. In this study, we performed single cell sequencing of paired TCR α and β
chains from EBV-specific CD8 T cells isolated at two time points (primary infection and
six months later in convalescence) from four individuals undergoing acute EBV infection.
We describe a TCRα sequence that was shared by all four individuals and identify con-
served residues within this sequence that likely contribute to viral recognition. Examina-
tion of the crystal structure of the peptide-MHC complex and subsequent experimental
data suggest that a specific interaction between a negatively charged aspartic acid at posi-
tion 4 of the peptide and a positively charged lysine in the TCR may be particularly impor-
tant. These findings are highly relevant to current efforts to understand how the TCR
repertoire may contribute to or protect against disease, the development of TCR diagnos-
tics for diseases, and at improving the efficacy of T cell based therapies.
Introduction
EBV infects almost 95 percent of the world’s population by the fourth decade of life. In
older children and adults, primary infection with EBV often manifests as acute infectious
mononucleosis (AIM), a self-contained illness characterized by fever, pharyngitis, lymph-
adenopathy and malaise. Activated virus-specific CD8 T cells are commonly expanded in
the peripheral blood in AIM followed by a contraction in convalescence. EBV-specific
memory CD8 T cells provide protection from EBV reactivation [1–5]. In HLA-A:02+ indi-
viduals, the EBV-specific CD8 T-cell response is dominated by responses to two lytic cycle
proteins, BRLF1 (BRLF1109-117 epitope: YVLDHLIVV) and BMLF1 (BMLF1280-288 epitope:
GLCTLVAML) [6, 7].
The interaction of CD8 TCRs with virus-derived peptides bound to MHC-I molecules
(pMHC) expressed on an infected cell surface [8–11] confers specificity of the CD8 T-cell
response. The TCR repertoire is an important determinant of CD8 T-cell-mediated antiviral
efficacy or immune-mediated pathology [12–17]. Each TCR is a membrane-bound, heterodi-
meric protein that is formed from two polypeptides: α and β. TCR diversity is generated
through recombination events, in which each chain arises from a random rearrangement of
variable (V), diversity (D), joining (J) and constant (C) gene segments [18]. The TCRβ chain
rearranges first, followed by the TCRα; the TCRα chain keeps rearranging until a TCRα chain
has been rearranged that is capable of successfully pairing with the TCRβ chain. The TCR is
then expresses on the surface of the T cell. Due to this sequence of events it is not unusual to
find T cells with the same TCRβ chain paired with different TCRα; reports of the reverse are,
however, rare. This recombination process results in a diverse pool of unique TCRα and β clo-
notypes. Additions of non-templated (N) nucleotides or deletions of nucleotides at the V(D)J
junctions, commonly known as the complementarity-determining region 3 (CDR3) and pair-
ing of different TCRα and β segments further enhance the overall diversity of the TCR reper-
toire, estimated to range from 1015−1020 unique potential TCRαβ clonotypes [15, 19].
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TCR repertoire analyses enable us to visualize the clonotypic identity of TCRs and to glean
information about important features that dictate antigenic specificity or recognition [20, 21].
Novel sequencing methods have shed important insights into the composition and organiza-
tion of the TCR repertoires of common pathogens. Despite the multitude of V and J genes and
virtually limitless number of TCRs that can be made from V(D)J recombination, skewing of
pathogen-specific repertoires have been observed [22–26]. These skewed repertoires have been
observed in the forms of preferential usage of particular V and/or J genes, as well as in conser-
vation of CDR3 motifs or sequences within and across individuals. There has been a growing
interest in understanding how these biases emerge, their immunological relevance, and their
implications for either protection or immunopathology [12, 20, 21, 26–28]. A caveat of the
majority of studies to date is that they have focused primarily on analyses of the TCRβ chain,
with little regard for the TCRα chain. One of the reasons that the mechanisms that shape T-
cell memory through TCRα selection have been difficult to delineate is due to technical con-
straints associated with the lack of VA-family specific antibodies. A T cell’s ability to co-
express two α-chains may also contribute [29, 30]. We performed single-cell TCRαβ sequenc-
ing of immunodominant GLC-BM (BMLF-1280 epitope) and YVL-BR-specific CD8 T cells
directly ex vivo over the course of primary infection and applied a newly developed analytical
tool [20] for the identification of significantly enriched features in epitope-specific TCR reper-
toires. This revealed selective use of particular AV genes in the YVL-specific TCR repertoire,
as well as identified novel pairing relationships between the α and β TCR chains. We identified
a TCRα chain, AV8.1-KDTDKL-AJ34, which was shared by all study participants. Addition-
ally, this chain was degenerate and paired with multiple different TCRβ chains in the same
individual, suggesting that it might be important for antigen recognition. To gain insight into
a potential basis for the conserved use of this TCRα chain, we solved the crystal structure of
the YVL-BR peptide-bound and uncovered a solvent-exposed Asp(D) at position 4 of the pep-
tide. Further examination of potential structural constraints suggests that a conserved Lys(K)
within the CDR3α of the TCRα clones may mediate contact with the protruding Asp(D) on
the YVL-BR peptide-bound MHC.
Results
Patient characteristics
Four HLA-A�02:01+ individuals presenting with symptoms of AIM and laboratory studies
consistent with primary infection were studied (S1 Table) at initial clinical presentation
(AIM) and 5–8 months later (Convalescence; CONV). Direct tetramer staining of peripheral
blood revealed that 2.7%±0.7 (mean±SEM) and 1.3%±0.3 of CD8 T cells were YVL-BR- and
GLC-BM-specific, respectively, in AIM; the frequencies of YVL-BR- and GLC-BM-specific
CD8 T cells declined to 0.3%±0.7 and 0.3%±0.1, respectively, in CONV.
The TCR repertoire is individualized and qualitative features distinguish
YVL-BR- and GLC-BM-specific TCR repertoires
To better understand the EBV-specific CD8 TCR repertoire, we performed single-cell paired
TCR sequencing of tetramer-sorted, epitope-specific CD8 T cells from four donors during
AIM and CONV. A total of 65 and 64 (YVL-BR; AIM and CONV) and 48 and 52 (GLC-BM;
AIM and CONV) productive paired TCRαβ sequences were generated (Tables 1 and S2). Cir-
cos plots were used to examine pairing relationships between AV and BV gene segments by
individual, epitope and time point (Fig 1). These analyses revealed that each individual had a
unique repertoire. For example, the pattern of AV-BV pairing for YVL-BR TCRs was more
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Table 1. Paired single-cell YVL-specific TCR amino acid sequences.
Color-coded by CDR3α clones Color-coded by CDR3β clones Count Count
Donor ID CDR3α CDR3β AIM CONV
E1632 AV8CAVKDTDKLIF AJ34 BV10CASMLPFGDEQYF BJ1 1
E1632 AV8CAVKDTDKLIF AJ34 BV10CASMLPFGDEQYF BJ2 1
E1655 AV8CAAPGAGSYQLTF AJ28 BV11CASMRELAGQETQYF BJ2 2
E1655 AV8CNASGAGSFHFTF AJ28 BV11CASMRELAGQETQYF BJ2 1
E1603 AV14CAMREGTGNFNKFYF AJ21 BV13CASRQTSGELFF BJ2 1 1
E1603 AV27SSPRFSDGQKLLF AJ16 BV13CASRQTSGELFF BJ2 1
E1603 AV8CAVKGGGADGITF AJ45 BV13CASRQTSGELFF BJ2 1
E1655 AV8CLIGQAGFTLIF AJ15 BV13CASSSPRGTGGRDTGELFF BJ2 1
E1651 AV12CAMSASNFGNEKLTF AJ48 BV15CATSSTARDSSYSNQPQHF BJ1 1
E1651 AV8CALSGGSQGNLIF AJ42 BV15CATSTGLAGIHEQYF BJ2 1
E1603 AV8CAVKDTDKLIF AJ34 BV19CASIAYLGSNQPQHF BJ1 1
E1655 AV8CAVNVPDGQKLLF AJ16 BV19CASRALLGGATEAFF BJ1 1 1
E1603 AV14CAMRGGVNNHNKFIF AJ21 BV19CASRTAGNSDTQYF BJ2 1
E1603 AV8CAVKDTDKLIF AJ34 BV19CASRTAGNSDTQYF BJ2 1 10
E1655 AV16CGVRNRDDKIIF AJ30 BV19CASSIGFDIETQYF BJ2 1
E1651 AV8CAVKDTDKLIF AJ34 BV19CASSSLLISEAFF BJ1 1
E1603 AV14CAMREGGNFNKFYF AJ21 BV20CSAAQALYNEQFF BJ2 1
E1655 AV3CAVREGGNFNKFYF AJ21 BV20CSAGQALRNEQFF BJ2 1
E1603 AV14CAMREGGNFNKFYF AJ21 BV20CSAGQVLEQPQHF BJ1 1
E1651 AV12CAMSASNFGNEKLTF AJ48 BV20CSANDRSYNEQFF BJ2 1
E1655 AV3SVVSTGARFNKFFF AJ21 BV20CSARDLAGNTGELFF BJ2 1
E1655 AV9CALRDTSGSRLTF AJ58 BV20CSARDSRDLLRGYTEAFF BJ1 1
E1651 AV25CAAGSNDYKLSF AJ20 BV20CSARGTLFYEQYF BJ2 1
E1651 AV8CAVNDNARLMF AJ31 BV20CSARGTSFYEQYF BJ2 1
E1603 AV25CAGSSNDYKLSF AJ20 BV20CSARGTTFYEQYF BJ2 1
E1655 AV22CAVGPLVRF AJ43 BV20CSASSNSAYGYTF BJ1 1
E1632 AV14CAMREGGNFNKFYF AJ21 BV20CSASYPAGLQAGGGDEQYF BJ2 2
E1651 AV14CAMRAGGNFNKFYF AJ21 BV20CSATIPPDNEQFF BJ2 1
E1632 AV3CAVRDGGNFNKFYF AJ21 BV20CSAVGLAGGFIVDEQFF BJ1 1
E1632 AV3CAVRDGGNFNKFYF AJ21 BV20CSAVGLAGGFIVDEQFF BJ2 1
E1603 AV14CAMREGGNFNKFYF AJ21 BV20CSGGQALHNEQFF BJ2 1
E1603 AV8CAVKDTDKLIF AJ34 BV24CATSDAHVNEQFF BJ2 1
E1651 AV8CAVNAHTDKLIF AJ34 BV24CATSDFLSNEQFF BJ2 1
E1655 AV38CASLNSGGGADGLTF AJ45 BV24CATSDPTRGRRNNEQFF BJ2 1
E1651 AV8CAVKDTDKLIF AJ34 BV24CATSDWDDSTGELFF BJ2 4 2
E1651 AV8CAVKNQAGTALIF AJ15 BV24CATSDWDDSTGELFF BJ2 1
E1632 AV8CAVKNQAGTALIF AJ15 BV25CASSEWGLGEAFF BJ1 1
E1632 AV25CAGATIGFGNVLHC AJ35 BV27CASGRLAGYNEQFF BJ2 1
E1632 AV22WAAGSGVGSFQLTF AJ28 BV27CASSFLGQTMNTEAFF BJ1 1
E1632 AV27CAGPLTGKLIF AJ37 BV27CASSFLGQTMNTEAFF BJ1 3 1
E1655 AV39CAVMRTYKYIF AJ40 BV27CASSLRGGGYEQYF BJ2 1
E1651 AV26CIVRGRNFGNEKLTF AJ48 BV27CASSLSITRVYEQYF BJ2 1
E1651 AV8CAVKDTDKLIF AJ34 BV27CASSLSMTHTYNEQFF BJ2 1
E1655 AV8CAVKQTDKLIF AJ34 BV27CASSPDIGWGGEQFF BJ2 1
E1655 AV8CAVKDTDKLIF AJ34 BV27CASSPSLSDYFTDTQYF BJ2 1
E1651 AV16CALRGSGNQFYF AJ49 BV27CASSPTTMLETQYF BJ2 1
(Continued)
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Table 1. (Continued)
Color-coded by CDR3α clones Color-coded by CDR3β clones Count Count
Donor ID CDR3α CDR3β AIM CONV
E1651 AV8CAVKDTDKLIF AJ34 BV27CASSRAASSSYNEQFF BJ2 1
E1651 AV25CAGLQGANNIFF AJ36 BV27CASSRDASSSYNEQFF BJ2 1
E1651 AV8CAVKDTDKLIF AJ34 BV27CASSRDASSSYNEQFF BJ2 3
E1651 AV8CAVKGTYKYIF AJ40 BV27CASSSNPMLETQYF BJ2 2
E1651 AV8SIGKGPDKLIL AJ34 BV27CASSSNPMLETQYF BJ2 1
E1651 AV17CATDADYGQNFVF AJ26 BV27CASSTVPGHQPQHF BJ1 3
E1655 AV8CALPGLNNDMRF AJ43 BV27CASSTYSGRATEQYF BJ2 1
E1603 AV8CAVNNQAGTALIF AJ15 BV28CAGRPLLGGGSPLHF BJ1 1
E1651 AV8CAVIAGGYQKVTF AJ13 BV28CANVMGGPEGGYTF BJ1 1
E1603 AV8CALKDTDKLIF AJ34 BV28CASRPWGGTGELFF BJ2 1
E1603 AV8CAVKNQAGTALIF AJ15 BV28CASRSSYNSPLHF BJ1 1
E1651 AV17CALNTGGFKTIF AJ9 BV28CASSLSGSRSEQFF BJ2 1
E1651 AV8CAVKDTDKLIF AJ34 BV28CASSSYPGLSTGELFF BJ2 1
E1651 AV8CAVSNTDKLIF AJ34 BV28CASSSYPGLSTGELFF BJ2 1
E1651 AV8CAVAGTGNQFYF AJ49 BV28CPAVPKGDSAPGTVFF BJ2 1
E1632 AV14CAMREGGNFNKFYF AJ21 BV29CSVAKPAGLAGGSNTGELFF BJ2 6
E1632 AV14CAMREGGNFNKFYF AJ21 BV29CSVGGTGSGTSGAYSYNEQFF BJ2 13 1
E1632 AV14GAMREGGNFNEFYC AJ21 BV29CSVGGTGSGTSGAYSYNEQFF BJ2 1
E1651 AV14CAMREGGNFNKFYF AJ21 BV29CSVGGTSGSVSYNEQFF BJ2 1
E1655 AV14CAMREGGNFNKFYF AJ21 BV29CSVGQALYNEQFF BJ2 1
E1651 AV14CAMREGGNFNKFYF AJ21 BV29CSVLDPTFSYNEQFF BJ2 1
E1632 AV19CALSSNARLMF AJ31 BV29CSVREAANYGYTF BJ1 1
E1655 AV14CAMREGGNFQKLVF AJ8 BV29CSVVAGANNEQFF BJ2 2
E1655 AV14CAMREGGNFNKFYF AJ21 BV29CSVVAPLWNEQFF BJ2 1
E1603 AV26CIVRVGGNFNKFYF AJ21 BV29CSVVEPPYNEQFF BJ2 1
E1651 AV14CAMREGGNFNKFYF AJ21 BV29CSVVTAPLTEQFF BJ2 1
E1655 AV14CAMREGGNFNKFYF AJ21 BV29CSVVWALGQPQHF BJ1 1 1
E1655 AV14KSYGGGASYGKLTF AJ52 BV29CSVVWALGQPQHF BJ1 1
E1655 AV3CAVNNARLMF AJ31 BV29CSVVWALGQPQHF BJ1 1
E1603 AV26CIVRVGGNFNKFYF AJ21 BV29PSVVEPPYNEQFF BJ2 1
E1655 AV1CAVRRGSTLGRLYF AJ18 BV2CASSAPGGTGGRNTEAFF BJ1 1
E1655 AV14CAMSAPPTSGSVRQLTF AJ22 BV2CASSSPLAESPAGELFF BJ2 1
E1651 AV8CAVKDTDKLIF AJ34 BV30CAWSGRPSYNEQFF BJ2 2
E1651 AV8CAVKATDKLIF AJ34 BV30CAWSGTPIYNEQFF BJ2 2
E1651 AV23CAASIPHFQAGTDLIF AJ15 BV30CAWSGTSPSSSYNEQFF BJ2 1
E1651 AV8CAVAGTGNQFYF AJ49 BV30CSGRGQSTSEQYF BJ2 1
E1651 AV8CAVKNTDKLIF AJ34 BV3CASSQDLGQIETQYF BJ2 1
E1655 AV10CVVSAPTGANKLIF AJ20 BV3CASSQDRAAYGYTF BJ1 1
E1651 AV8CAQGDAGNMLTF AJ39 BV3CASSQEPGSGETQYF BJ2 1
E1603 AV8CAVNNAGNMLTF AJ39 BV3CASSQEPLSGDTQYF BJ2 1
E1655 AV8CAVGNTGKLIF AJ37 BV3CASSQGISSGNTIYF BJ1 2
E1651 AV13CAERRGGNFNKFYF AJ21 BV3CASSQGLADGETQYF BJ2 1
E1651 AV27CARGNEKLTF AJ48 BV3CASSQGLSGRAHEQFF BJ2 1
E1651 AV8CAVSSAGKSTF AJ27 BV3CASSQGPSSGNTIYF BJ1 1
E1655 AV8CAVKDTDKLIF AJ34 BV3CASSQVIGVGYTF BJ1 1
E1655 AV8CAFGGYNKLIF AJ4 BV4CASSDVTGTYGYTF BJ1 1
(Continued)
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intricate in some individuals (E1655 and E1651), as demonstrated by the dense interaction
web, than in others (E1603 and E1632) (Fig 1A). However, despite the uniqueness of the reper-
toire, there were prominent features shared across individuals and these features were peculiar
to each epitope. Such features included the use of AV8.1 by YVL-BR TCRs in all individuals in
both AIM and CONV. This gene was overrepresented in three of the four donors (E1603,
E1655, and E1651) and paired with multiple BV genes (Fig 1A). The pairing of AV8.1 with
multiple BV genes was more pronounced in E1651 and E1655. The BV repertoire of YVL-BR
used multiple different families that differed between the donors with no obvious shared fea-
tures. With respect to GLC-BM, although there were difference between the donors, AV5 and
Table 1. (Continued)
Color-coded by CDR3α clones Color-coded by CDR3β clones Count Count
Donor ID CDR3α CDR3β AIM CONV
E1651 AV8CAVKDTDKLIF AJ34 BV4CASSNTAGVLGDEQFF BJ2 1
E1655 AV26CILRDSHTGTASKLTF AJ44 BV5CASKSLSSYEQYF BJ2 1
E1655 AV12CAVGNTNAGKSTF AJ27 BV5CASSLAAREDEQYF BJ2 1
E1651 AV25CAYYNFNKFYF AJ21 BV5CASSLELAGANSYEQYF BJ2 1
E1632 AV8CAGYNFNKFYF AJ21 BV5CASSLFSGNEQFF BJ2 1
E1651 AV8CAVIFFNKFYF AJ21 BV5CASSLGASGSSEQFF BJ2 1
E1655 AV8CAVKDTDKLIF AJ34 BV6CARSGTSDTLSYNEQFF BJ2 1
E1603 AV8CALNSNYQLIW AJ33 BV6CASRALSGGGQPQHF BJ1 1
E1632 AV22CAAGSGAGSYQLTF AJ28 BV6CASRHPLGGASEQYF BJ2 1
E1651 AV8CAVNSDYKLSF AJ20 BV6CASRQLTGGAQPQHF BJ1 1
E1632 AV8CAVGNYQLIW AJ33 BV6CASRQQGSTEAFF BJ1 1
E1603 AV8CAGKGGGADGLTF AJ45 BV6CASSALLGSASTQYF BJ2 1
E1603 AV8CAVKGGGADGLTF AJ45 BV6CASSALLGSASTQYF BJ2 10 14
E1655 AV1CAVNNDYKLSF AJ20 BV6CASSASPGGAGNEQFF BJ2 1
E1655 AV8CAVKDTDKLIF AJ34 BV6CASSDTLSTGELFF BJ2 1
E1651 AV16CALKDTDKLIF AJ34 BV6CASSEFSMYEAFF BJ1 1
E1603 AV8CAFYHAGNMLTF AJ39 BV6CASSGPGWDEQYF BJ2 1
E1655 AV3CAVNNARLMF AJ31 BV6CASSPDSYEQYF BJ2 1
E1655 AV8CAVKDTDKLIF AJ34 BV6CASSSFRDSSNEQYF BJ2 2
E1655 AV12CAVNGPPPSGSARQLTF AJ22 BV6CASSSTYPGSVGETQYF BJ2 1
E1603 AV8CAVKDTDKLIF AJ34 BV6CASSSVLDFLGTGELFF BJ2 1
E1655 AV8CAVKDTGKLIF AJ37 BV6CASSVIDTQYF BJ2 1
E1651 AV8CAVKDTDKLIF AJ34 BV6CASSVPTLSDGYTF BJ1 1
E1632 AV21CAVPMYSGGGADGLTF AJ45 BV6CASSYIGVGYTF BJ1 1
E1632 AV22CAAGSGAGSYQLTF AJ28 BV6CASSYPTGHSSYNEQFF BJ2 17
E1632 AV22CAAGSGVGSYQLTF AJ28 BV6CASSYPTGHSSYNEQFF BJ2 1
E1632 AV22RDAGCGAGSYQFTF AJ28 BV6CASSYPTGHSSYNEQFF BJ2 1
E1603 AV8CAVKDTDKLIF AJ34 BV6CASSYVGLLGDTQYF BJ2 1
E1651 AV26CILRGPPLGNEKLTF AJ48 BV6CASTGIQGNTGELFF BJ2 1
E1651 AV8CAVNAVGDMRF AJ43 BV7CASSAGQGSGNTIYF BJ1 1
E1651 AV26CIVPSTSGTYKYIF AJ40 BV7CASSLAGINYGYTF BJ1 1
E1632 AV8CAVKNQAGTALIF AJ15 BV7CASSPDPTGYNEQFF BJ2 1
E1651 AV8CAVKNQAGTALIF AJ15 BV7CASSQGPTGDTQYF BJ2 1
E1651 AV8CAVSEGTNAGKSTF AJ27 BV7CASSYTGRALEAFF BJ1 1
E1651 AV8CAVVTGGFKTIF AJ9 BV7CASSYTTGSADTQYF BJ2 1
E1651 AV12CVVNRLDNAGNMLTF AJ39 BV9CASSVAGTSVETQYF BJ2 1
https://doi.org/10.1371/journal.ppat.1008122.t001
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Fig 1. Patterns of AV-BV pairings by YVL-BR (A) and GLC-BM (B) specific CD8 T-cells as revealed by single-cell TCRαβ sequencing.
The frequencies of AV-BV combinations in four donors during AIM (i) and CONV (ii) for YVL-BR- (A) and GLC-BM-specific (B) TCRαβ
repertoires are displayed in circos plots, with frequency of each AV or BV cassette represented by its arc length and that of the AV-BV cassette
combination by the width of the joining ribbon. The numbers of unique and productive paired TCRαβ clonotypes as well as the total numbers
of sequences for each donor are shown below the pie charts (# of unique TCRαβ clonotypes; total # of sequences).
https://doi.org/10.1371/journal.ppat.1008122.g001
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BV20 were common in all four patients in AIM and CONV. The public AV5-BV20 pairing
was conserved in all individuals (Fig 1B), consistent with previous reports [31, 32].
The selection of the YVL-BR-specific repertoire is mainly driven by TCRα
The qualitative analysis of the repertoire discussed above suggested the presence of generaliz-
able features associated with epitope-specific TCRs. To quantitatively evaluate these features,
we used a TCRαβ sequence-based analytical tool recently developed by Dash and colleagues
[20]. This tool identifies features that are significantly enriched in an epitope-specific reper-
toire by quantifying different properties of an epitope-specific TCR repertoire and comparing
them against a collection of publicly available human TCR sequences. The Shannon-Jensen
divergence is used to identify significantly enriched gene segments (Fig 2A) and to score the
magnitude of preferential gene usage (Fig 2B) within an epitope-specific repertoire, then the
adjusted mutual information is used to measure the magnitude of gene usage correlations
within and across TCRα/β (Fig 2C). In order to work with a large dataset, we merged the data
from all patients, per time point and per epitope. We first examined the pattern of VA-JA/
VB-JB gene segment pairing by ribbon plots (Fig 2A). There were identifiable enriched gene
segments and pairings. For example, the AV8.1/AJ34 pairing was significantly enriched in the
YVL-BR repertoire in AIM and CONV but paired with multiple different BV/JB genes (Fig
2A). In contrast, the AV5/AJ31 combination paired with BV20.1/ BJ1.3 was significantly
enriched in the GLC-BM repertoire in AIM and CONV (Fig 2A).
To quantitatively evaluate the degree of bias in the repertoire, we evaluated the gene prefer-
ence score. We observed that YVL-BR-specific CD8 T cells exhibited a strong preferential
usage of particular AV and AJ in both AIM and CONV. By contrast, GLC-BM-specific TCRs
exhibited strong preferential usage of particular AV, AJ, BV and BJ (Fig 2B). This is consistent
with previous structural studies demonstrating that both the TCR α and β chains are impor-
tant for recognition of the GLC-BM epitope [33]. Altogether, these data suggest that the TCRα
chain may be important for selection of YVL-BR-specific CD8 T cells whereas both the TCR α
and β chains together are important for selection of GLC-BM-specific CD8 T cells. Moreover,
quantification of the degree of gene usage correlations within and across TCRα/β revealed that
GLC-BM-specific TCRα and β repertoires were rigid; every gene association except for two in
AIM (AV-AJ and AV-BJ pairings) and one in CONV (AV-BJ) were enriched and thus impor-
tant for selection into the repertoire (Fig 2C). In contrast, the YVL-BR repertoire was highly
flexible in gene pairings. No obvious gene associations emerged for YVL-BR-specific TCR in
AIM, whereas only the AV-AJ association emerged as important in CONV (Fig 2C). These
data highlight the differences in selection of the YVL-BR and GLC-BM TCR repertoires at the
clonal level.
Identification of a shared public and dominant CDR3α,
AV8.1-KDTDKL-AJ34 that pairs with multiple different BV genes within
the YVL-BR repertoire
To dissect the clonal composition of the TCRαβ repertoires, we clustered similar clones into
groups (Figs 3 and 4) by performing a number of analyses including 2D kernel principal com-
ponent analysis (kPCA) projections (Fig 4C–4D) and hierarchical clustering with dendograms
(Figs 3 and S3) for YVL-BR (C) and GLC-BM (D) specific responses (n = 4 donors pooled in
AIM and CONV). In the 2D kPCA projections, the color correlates to gene usage. The hierar-
chical clustering is presented as a dendogram of the paired TCRαβ clones and also derived
TCR logo representations showing gene usages and frequencies and CDR3 amino acid
sequences of specific clusters (Figs 3 and 4C and S3). For the YVL-BR response, clustering
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was driven by the TCRα chain, particularly the dominant AV8.1-KDTDKL-AJ34 expressing
clones; this TCRα chain was detected in all individuals and resulted from an obligate pairing
between AV8.1 and AJ34 (Fig 3). More importantly, this public AV8.1-KDTDKL-AJ34 TCR is
so important for selection of the YVL-BR TCR repertoire that there is an unusually high fre-
quency of clones where this one TCRα chain pairs with multiple different TCRβ chains within
a single donor (median 4; range: 1–9) (Fig 3 and Table 2). It is not uncommon to find a single
TCRβ chain to rearrange and pair with multiple different TCRα as TCRβ rearranges first and
is expressed before TCRα. Because of this order in TCR rearrangement, it would be less com-
mon to see multiple TCRβ with the same TCRα. This finding suggests that this TCRα is so
highly favored by its interaction with EBV-BR/MHC that these rare event TCR rearrange-
ments dominate the repertoire. In contrast, in the GLC-BM TCR repertoire there was no evi-
dence of such pairing of a single public TCRα chain being paired with multiple different TCRβ
chains or vice versa. Unlike YVL-BR, the clustering of GLC-BM-specific TCRs was driven by
dominant interactions with both the TCRα and β chains (Figs 4D and S3).
Predictable CDR3α motif features drive the selection of the shared
AV8.1-KDTDKL-AJ34 expressing clones
To better understand the factors driving the selection of AV8.1-KDTDKL-AJ34 expressing
clones, we analyzed CDR3 sequences for motifs and conserved residues that may determine
epitope recognition [20]. The analytical tool reported by Dash and colleagues [20] is a predic-
tive algorithm for the identification of key enriched residues within CDR3 regions that may be
important in antigen recognition, known as the CDR3 motif. It is based on the principle that
amino acids within the CDR3 which do not tolerate substitutions when comparing clusters of
Fig 2. Single-cell paired TCRαβ sequencing provides evidence that the selection of YVL-BR-specific repertoire is mainly driven by TCRα. (A) Gene segment usage
and gene–gene pairing landscapes for all four donors, combined, during AIM and CONV for YVL-BR- (Top) and GLC-BM-specific (Bottom) TCRαβ repertoires are
illustrated using four vertical stacks (one for each V and J segment) connected by curved paths whose thickness is proportional to the number of TCR clones with the
respective gene pairing (each panel is labeled with the four gene segments atop their respective color stacks and the epitope identifier in the top middle). Genes are colored
by frequency within the repertoire, which begins red (most frequent), green (second most frequent), blue, cyan, magenta, and black. The enrichment of gene segments
relative to background frequencies is indicated by up or down arrows with an arrowhead number equal to the log2 of the fold change. (B), Jensen–Shannon divergence
between the observed gene frequency distributions and background frequencies, normalized by the mean Shannon entropy of the two distributions (higher values reflect
stronger gene preferences). (C), Adjusted mutual information of gene usage correlations between regions (higher values indicate more strongly covarying gene usage).
Analyses are based on Dash et. al. [20].
https://doi.org/10.1371/journal.ppat.1008122.g002
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similar TCRα or β chain sequences must be important for interaction with the pMHC. It also
identifies sequence patterns or motifs that occur more frequently in an epitope-specific TCR
repertoire compared with a background dataset, which consists of publicly available and ran-
domly selected unpaired non-epitope-specific TCRs derived from high-throughput TCR rep-
ertoire profiling [34–37] and calculates fold enrichment of the observed motifs in epitope-
specific repertoires over the expected in the background dataset (Fig 4A and 4B).
With this useful algorithm, for GLC-BM we identified a known [20, 33] highly public domi-
nant CDR3α motif AEDNNA, with a conserved Asp(D) residue within these public AV5-AJ31
Fig 3. Hierarchical clustering of TCRs highlights the structural features required for interaction with pMHC of paired TCRα/β. (A-B) Hierarchical TCRαβ
clustering along with corresponding TCR logos for YVL-BR-specific CD8 T-cell responses in AIM (A) and CONV (B). Number on the branches and next to TCR logos
depicts number of TCRs contributing to the cluster. Color of the branches indicates the TCR probability generation scores. The bar at the bottom of the CDR3 logo is
color-coded by the source of the nucleotide. Light grey, red, black, and dark grey denote that the nucleotides encoding those amino acid residues originate from the V, N,
D and J regions, respectively. Analyses are based on Dash et al. [20].
https://doi.org/10.1371/journal.ppat.1008122.g003
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expressing clones (Fig 3Bi). We also identified two known [20, 33] CDR3β motifs, RDxTGN
within the public BV20.1-expressing clones in CONV and S/P,T/P,S/G,G within the public
BV14-expressing clones in AIM (Fig 3Bii) as being important for GLC-BM recognition. We
should note that CDR3 motifs that were identified within the GLC-BM response during AIM
used similar clonotypes in CONV, particularly the highly public AV5-AEDNNA-J31 paired
with VB20.1-SARDXXGN-J1.2/1.3, consistent with observations from deep sequencing data
Fig 4. Single-cell CDR3α (i) and β (ii) motif analyses of YVL-BR- (A) and GLC-BM- (B) specific CD8 T cells during AIM and CONV. CDR3α or β sequences were
pooled from all 4 patients during AIM and CONV. Using TCRlogo in TCRdist algorithm, top-scoring CDR3β and CDR3α motifs are shown for each group. V and J gene
usage are indicated on the left and right side of TCR logos, respectively. The top logo is based on comparing clusters of similar clonotypes comparing where the CDR3
tolerates or does not tolerate mutations or alternate amino acids. The bottom panel highlights the enriched amino acids within the motif by calculating against a
background dataset of naïve non-YVL-BR or GLC-BM-specific CD8 TCRs. The bar at the bottom of the CDR3 logo is color-coded by the source of the nucleotide. Light
grey, red, black, and dark grey denote that the nucleotides encoding those amino acid residues originate from the V, N, D and J regions, respectively. (C-D) 2D kernel
principal component analysis (kPCA) projections for YVL-BR (C) and GLC-BM (D) specific responses (n = 4 donors pooled in AIM and CONV). Color correlates with
gene usage. Most prevalent gene usages are mentioned within the plots matching with clonotype color. Each row represents group and each column is the same 2D kPCA
projection of the four gene segment usage (Vα, Jα, Vβ, and Jβ). Analyses are based on Dash et al. [20].
https://doi.org/10.1371/journal.ppat.1008122.g004
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of a strong selection of these particular clonotypes into CONV (Gil et al., manuscript submit-
ted, 2019).
In the YVL-BR-specific TCR repertoire, we discerned a strong CDR3α motif and some
CDR3β motifs (Fig 4A and 4C). Within the public AV8.1/AJ34 clonotypes, the CAVKDTKL
motif was highly conserved (Fig 4A) from AIM to CONV and contained the conserved amino
acid pair “KD” which is partially non-germline (S2 Fig), suggesting that they may provide a
selective advantage and play a critical role in YVL-BR recognition. There was a second CDR3α
motif (CAXRxGGN) that included a conserved “GG” pair predominantly resulting from the
AV14-AJ21 recombination event. Interestingly, although many different BV were used in the
YVL-BR response, this algorithm identified two potential CDR3β motifs, “xAxL”, present in
AIM and “GTSx” present in CONV, resulting from multiple BV-BJ recombination events; this
suggests that TCRβ may play some role in selection of YVL-BR-specific TCRs but it differs
between AIM and convalescence.
To experimentally test whether the first Lys(K) in the CAVKDTKL motif and present in the
highly conserved amino acid pair, “KD” was important for YVL-BR recognition, we cloned
one of the YVL-BR-specific TCR expressing the AV8.1-CAVKDTKL-AJ34 motif (wild-type,
WT,TCR; AV8.1-CAVKDTDKLIF-AJ34BV24.1-CATSDWDDSTGELFF-BJ2.2). We con-
firmed the antigenic specificity of the cloned WT TCR by expressing it in TCR-null CD8α-
expressing J76 cells; the TCR-transduced cells stained with YVL-BR tetramer (Fig 5Ai and
5B). To determine whether the Lys(K) within the conserved “KD” amino acid pair was
involved in antigen recognition, we mutated the WT TCR (K113A TCR). This mutation abro-
gated YVL-BR tetramer staining (Fig 5Aii and 5B), consistent with this Lys(K) contributing to
YVL-BR/MHC recognition. We confirmed that the mutated TCR was expressed by measuring
CD3 upregulation (S1 Fig), which excludes the possibility that the lack of tetramer staining
was due to a lack of TCR expression. Increasing the amount of YVL-BR tetramer did not result
in tetramer staining to the mutated TCR (K113A; Fig 5B). Additionally, we observed
Table 2. TCR AV8-CAVKDTDKLIF-AJ34 pairs with multiple different TCRβ within the same individual.
Donor ID AV CDR3α sequence (AA) AJ CDR3α length BV CDR3β sequence (AA) BJ CDR3β length
E1603 AV08 AVKDTDKLI AJ34 9 BV24 ATSDAHVNEQF BJ02 11
BV06 ASSYVGLLGDTQY BJ02 13
BV06 ASSSVLDFLGTGELF BJ02 15
BV19 ASRTAGNSDTQY BJ02 12
E1632 AV08 AVKDTDKLI AJ34 9 BV10 ASMLPFGDEQY BJ01 11
E1651 AV08 AVKDTDKLI AJ34 9 BV30 AWSGRPSYNEQF BJ02 12
BV24 ATSDWDDSTGELF BJ02 13
BV06 ASSVPTLSDGYT BJ01 12
BV28 ASSSYPGLSTGELF BJ02 14
BV19 ASSSLLISEAF BJ01 11
BV27 ASSRDASSSYNEQF BJ02 14
BV27 ASSRAASSSYNEQF BJ02 14
BV04 ASSNTAGVLGDEQF BJ02 14
BV27 ASSLSMTHTYNEQF BJ02 14
E1655 AV08 AVKDTDKLI AJ34 9 BV06 ASSSFRDSSNEQY BJ02 13
BV03 ASSQVIGVGYT BJ01 11
BV27 ASSPSLSDYFTDTQY BJ02 15
BV06 ASSDTLSTGELF BJ02 12
BV06 ARSGTSDTLSYNEQF BJ02 15
https://doi.org/10.1371/journal.ppat.1008122.t002
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functional signaling through the wild-type TCR as measured by the upregulation of CD69 fol-
lowing stimulation of the WT TCR-transduced J76 cells with peptide-pulsed HLA-A2-expres-
sing T2 cells acting as antigen presenting cells (Fig 5C). Introduction of the K113A mutation
substantially decreased CD69 upregulation, further indicating that Lys(K) contributed to
Fig 5. Proposed mechanism for the selection of the public AV8.1-CAVKDTDKLIF-AJ34 clonotype. (A) Tetramer staining of J76-cells transduced with either the WT
(i) or mutant K113A TCR (ii) and stained with the cognate A2-YVL-BR (purple) or an irrelevant A2-GLC-BM (grey) tetramer. CDR3α/β sequences are noted below each
TCR name. The bold residue in the CDR3α denotes the one that has been mutated. (B) Tetramer titration of J76-cells transduced with either the WT (blue) or mutant
K113A TCR (red). Assay was performed in three technical replicates and mean ± SD is shown. (C) CD69 upregulation of J76-cells transduced with either the WT (blue) or
mutant K113A TCR (red). The cells were stimulated with T2-cells pulsed with the respective peptides at different concentrations (10−9, 10−8, 10−7, 5 x 10−7 and 10−6 M).
HLA-A2-restricted epitope derived from tyrosinase protein (YMDGTMSQV) was used as a negative control. Amino acid sequences of the WT and mutant BRLF-1109−117
peptides are shown in parentheses. The bold residue in the peptide sequence denotes mutated residue (D4A mutant peptide). Assays were performed in two technical and
biological replicates and mean ± SD is shown. (D) Crystal structure of YVL-BR pMHC. Top, top view (or TCR-view) of HLA-A2/YVL-BR complex, with peptides atoms
shown as spheres and HLA-A2 surface in tan. Peptide sequence indicated in single letter code. Bottom, cut-away side view of HLA-A2/YVL-BR complex with peptide in
stick model and HLA-A2 as a ribbon. The alpha-2 helix in front of the peptide was removed for clarity. Statistical analyses were done using multiple t tests. �: p
value< 0.01. WT: wild-type.
https://doi.org/10.1371/journal.ppat.1008122.g005
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YVL-BR/MHC recognition (Fig 5C). Of interest, a small functional response was still induc-
ible even though tetramer no longer bound to this mutated TCR, consistent with previous
studies demonstrating induction of functional response but no tetramer binding when using
variant ligands [17, 38–40]. To further dissect the role of the Lys(K) within the KD motif, we
investigated the effect of D4!A peptide mutation (D4A mutant peptide) on CD69 upregula-
tion on cells expressing the WT TCR (Fig 5C). We observed that J76 cells expressing the WT
TCR and stimulated with T2 cells pulsed with either the WT peptide or the D4A mutant pep-
tide displayed levels of CD69 upregulation not significantly different from background levels
(cells stimulated with a non-cognate HLA-A2-restricted epitope derived from the protein
tyrosinase) at peptide concentration of 10−9 M and 10−8 M. However, as peptide concentration
increased, CD69 expression on WT TCR-expressing cells stimulated with D4A mutant peptide
at peptide concentrations of 5x10-7 and 10−7 M was significantly reduced compared to those
stimulated with the WT peptide. These observations suggest that the Asp(D) residue at posi-
tion 4 of the peptide plays a role in mediating T-cell signaling. However, the Lys(K) on the
CDR3α may play a more important role given that mutation of this residue led to substantial
reduction of CD69 upregulation. Further structural analyses of the TCR with its cognate ligand
will be necessary to ascertain the existence of an interaction between the Lys(K) in the “KD”
CDR3α motif and Asp(D) at position 4 on the peptide.
Structural features of YVL-BR/MHC support the role of Vα in selection of
the YVL-BR-specific TCR repertoire
We next determined the crystal structure of the HLA-A2/YVL-BR complex in order to identify
specific structural features that might be associated with the dominant AV8.1-KDTDKL-AJ34
usage in the YVL-BR-specific TCRs (Fig 5D). Structure determination was complicated ini-
tially by the relatively low resolution (S3 Table) and high degree of translational pseudosym-
metry (S4A and S4D Fig) that characterized the HLA-A2/YVL-BR crystals (see Methods), but
ultimately clear and continuous electron density extending the full length of the peptide
allowed confident location of all peptide atoms (S4E–S4F Fig). In the HLA-A2 complex, the
nonameric YVL-BR peptide is bound in conventional orientation, with the amino terminus
and side chains of Val(V) at position 2 and Val(V) at position 9 accommodated in pockets (A,
B, and F, respectively) in the peptide binding site. Notably, the side chains of Tyr(Y) at position
1, highly negative charged Asp(D) at position 4, and His(H) at position 5 project away from
the binding site, and compose a highly featured surface positioned for recognition by CDRα
loops of a TCR bound in conventional orientation (Fig 5D). By contrast, the side chains of Leu
(L) at position 6, Ile(I) at position 7, and Val(V) at position 8, together with exposed main-
chain atoms, present a rather non-descript generally hydrophobic surface positioned to inter-
act with CDRβ loops of a TCR bound in conventional orientation.
Discussion
We report the use of single-cell TCR sequencing on tetramer-sorted EBV-specific CD8 T cells
to study the TCR repertoires at the clonal level to a previously unstudied immunodominant,
HLA-A2-restricted EBV epitope, YVL-BR, comparing it to GLC-BM repertoires in the same
donors. Our studies are unique since they examined both CD8 TCR α and β directly ex vivo
from the peripheral blood of individuals during primary EBV infection (AIM) and again 6
months later in convalescence (CONV). Although the TCR repertoire was individualized (i.e.,
each donor studied had a unique TCR repertoire), there were prominent public features that
were significantly enriched and shared across individuals.
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We identified a CD8 T-cell repertoire to a dominant human viral epitope, YVL-BR, that
was significantly biased towards TCRα usage based on the CDR3α. We identified a ubiquitous
and public TCRα chain, AV8.1-KDTDKL-AJ34, that paired with multiple different TCRβ
chains in the same donor. In contrast and consistent with prior reports, GLC-BM-specific
CD8 T-cell repertoires were notably skewed in both TCRα and TCRβ usage with a bias
towards use of the public AV5-AJ31-BV20-BJ1.2 combination.
Prominent biases have been noted in the TCR repertoire of various common virus-specific
CD8 T cells (influenza, cytomegalovirus, hepatitis C virus) [20, 22, 23, 25, 26, 28, 41]. However,
most studies to date have only examined the TCRβ chain. The TCRα repertoire has been
under-appreciated due to the technical constraints associated with the lack of VA-family spe-
cific monoclonal antibodies and the potential for T cellsto co-express two α-chains [29, 30].
The apparent selection of a strongly TCRα-driven YVL-BR repertoire suggests that examina-
tion of the TCRα repertoire as well as the TCRβ provides a more comprehensive view of an
epitope-specific TCR repertoire.
There have been limited reports of the importance of TCRα in viral epitope-specific
responses but this appeared to relate to TCR CDR1α interaction with the MHC as observed
with the HLA-A�02-restricted yellow fever virus epitope, LLWWNGPMAV which has a biased
TRAV12.2 usage [42]. HLA-B�35:08 restricted EBV BZLF1-specific responses appear to be
biased in both TCRα and TCRβ usage, much like HLA-A2-restricted GLC-BM [43, 44]. There
is a strong preservation of a public TCRα clonotype, AV19-CALSGFYNTDKLIF-J34, which
can pair with a few different TCRβ chains. TCRα chain motifs have also been described for
HLA-A02:01-restricted MI58-67 (GIL-M1) IAV-M1, but these appear to make minor contribu-
tions to the pMHC-TCR interaction, which is almost completely dominated by CDR3β [26,
30, 45].
The TCR repertoire of the HLA-A02:01-restricted MI58-67 (GIL-M1) epitope from influenza
A virus is highly biased towards the TRBV19 gene in many individuals and displays a strong
preservation of a dominant xRSx CDR3β motif. Crystal structures of TCR specific to this epi-
tope have revealed that the TCR is β-centric with residues of the TRBV19-encoded CDR1 and
CDR2 loops engaging pMHC and the conserved arginine in the CDR3β loop being inserted
into a pocket formed between the peptide and the α2-helix of the HLA-A02:01 [26, 46]. The
TCRα is not as important as the TCRβ in pMHC engagement and this helps explain the high
degree of sequence conservation in the CDR3β and the variability in the CDR3α. Similarly,
studies using EBV virus GLC-BM-specific CD8 T cells have documented that TCR-pMHC
binding modes also contribute to TCR biases. Miles and colleagues [33] showed that the highly
public AS01 TCR, which is specific to the HLA-A�02:01-restricted EBV-derived GLC epitope,
was highly selected by the GLC-BM epitope because of a few very strong interactions of its
TRAV5- and TRBV20-encoded CDR3 loops with the peptide/MHC.
Given the aforementioned studies, we reasoned that the differences in constraints in the
TCR repertoires of YVL-BR and GLC-BM may give a picture of the essential requirements of
antigen recognition and that the topology of the pMHC may provide some structural insights
into the mechanisms underlying these constraints. This alpha-centricity displayed by the
YVL-BR repertoire might be grounded in the fact that the TCRα chain makes more pro-
nounced contact with its ligand, the pMHC, compared to the TCRβ chain. In light of this
apparent TCRα bias in the YVL-BR repertoire and the substantial evidence that TCR-pMHC
binding modes also contribute to TCR biases, we hypothesized that the bias for TCRα in the
YVL-BR repertoire most likely reflects an inherent feature of how the YVL-BR peptide lies in
the HLA-A2 groove or the topology of the pMHC. To understand why the YVL-BR epitope
drives the selection of this highly conserved public TCRα, we applied the Dash et al. algorithm
[20] to identify key amino acid residues that might be important for antigen recognition. We
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uncovered the AV8.1- KDTDKL-AJ34 motif with the highly conserved “KD” amino acid pair
within this clonotype as being potentially critical for recognition of the YVL-BR epitope.
These motifs and conserved residues suggest a structural basis for YVL-BR recognition.
Our structural analysis revealed that the MHC-bound YVL-BR bulged at position 4, in a
region of the peptide that TCRα would have to accommodate, exposing a negatively charged
Asp(D). We cloned a TCR expressing the dominant public TCRα chain AV8.1-KDTDK-
L-AJ34 and using mutagenesis, we provided evidence indicating that the positively charged
Lys(K) residue in the CDR3α of the public TCRα chain was important for YVL-BR/MHC rec-
ognition. Hence, we propose that the preferential selection of AV8.1-KDTDKL-AJ34, which
contains the positively charged (Lys)K in position 1, is potentially driven by an electrostatic
interaction between this Lys(K) and the solvent-exposed Asp(D) on the peptide. Future struc-
tural analyses of this TCRαβ with its ligand would be important to validate the existence of this
electrostatic interaction and to confirm whether the TCRα contributes the majority of contacts
with the pMHC. This apparent preference for TCRα may create a large repertoire of different
memory TCRβ that could potentially cross-react with other ligands such as IAV-M158, which
predominantly interact with TCRBV[17, 20, 26].
In summary, we describe a virus-specific TCR repertoire that is CDR3α-centric and have
proposed a structural basis for the selection of a public TCRα chain with a conserved CDR3
motif that seemingly relies on the topology of the pMHC. These studies underscore the impor-
tance of studying the TCRα, which has been underappreciated, as well as the TCRβ chains in
order to get a complete picture of the determinants of TCR selection. Our findings will con-
tribute to the growing interest and effort focused on the ability to predict the specificity and
efficacy of TCR from sequence analyses for the fundamental goal of designing better T-cell
therapies [12, 20, 21, 47–49].
Materials and methods
Study population
Four individuals (E1603, E1632, E1655 and E1651) presenting with symptoms consistent with
acute infectious mononucleosis (AIM) and laboratory studies consistent with primary infec-
tion (positive serum heterophile antibody and the detection of EBV viral capsid antigen
(VCA)-specific IgM) were studied as described [17]. Blood samples were collected in heparin-
ized tubes at clinical presentation with AIM symptoms (acute phase) and six months later
(memory phase). PBMC were extracted by Ficoll-Paque density gradient media.
Ethics statement
The Institutional Review Board of the University of Massachusetts Medical School approved
these studies, and all participants were adults and provided written informed consent.
Isolation of YVL-BR- and GLC-BM-specific CD8 T-cells by tetramer
staining and single-cell sorting directly ex vivo
The percentages of peripheral blood antigen-specific CD8 T-cells were measured by tetramer
staining and flow cytometry. Antibodies were purchased from BD Biosciences and included:
anti-CD3-FITC, anti-CD4-AF700 and anti-CD8-BV786, 7AAD and PE-conjugated
HLA-A�02:01-peptide tetramers (BRLF-1109−117: YVLDHLIVV, A2-YVL-BR; BMLF-1280−288:
GLCTLVAML, A2-GLC-BM). Tetramers were made in-house and underwent quality assur-
ance, as previously described [50]. Total CD8 T-cells were enriched from PBMCs by positive
selection using MACS technology (Miltenyi Biotec, Auburn, CA) according to the
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manufacturer’s protocol. The cells were then stained with anti-CD3, anti-CD4, anti-CD8,
7AAD, and GLC-BM- or YVL-BR-loaded tetramers for 30 minutes on ice in staining buffer
(1% BSA in PBS). Single-cell (into 384-well PCR plates) (FACSAria III, BD) of live CD3+,
CD8+, and GLC-BM- or YVL-BR-tetramer+ cells were sorted by flow cytometry for subse-
quent TCR analysis.
Single-cell cDNA synthesis and paired TCRαβ analysis of EBV-specific
CD8 T-cells
To examine TCRα and TCRβ pairing relationships, we conducted an ex vivo single-cell analy-
sis of the paired TCRαβ repertoire of YVL-BR and GLC-BM-specific CD8 T-cells from
PBMCs of the 4 donors in AIM and CONV. Single tetramer-positive CD8 T cells were sorted
into a 384-well plate containing 0.5 ul of lysis buffer, consisting of a mixture of Triton X 100
(Sigma, St. Louis, MO), RNase inhibitor (Clontech, Mountain View, CA), 3’ SMART CDS
Primer IIA (Clontech, Mountain View, CA), using the FACSARIA (BD Biosciences, San Jose,
CA). Reverse transcription and global amplification of full-length cDNA was performed using
the SMARTer kit (Clontech, Mountain View, CA) as described by the manufacturer. The syn-
thesized cDNA library was used as template to amplify CDR3α/β as previously described [51].
Briefly, amplification involves a two-step multiplex PCR using a pool of 20 and 22 forward
primers specific to Vα and Vβ gene families and two reverse primers, each specific to Cα or
Cβ. The PCR products were purified and individually analyzed by Sanger sequencing. Nucleo-
tide sequences (see S4 Table) were analyzed according to the IMGT/V-QUEST web-based tool
[52]. Only productively rearranged CDR3α and CDRβ sequences without stop codons were
used for repertoire analyses.
Ribbon plots, gene correlations and gene preferences. An analytical tool developed by
Dash et. al. [20] was used to characterize patterns of gene segment usage by ribbon plots, corre-
late gene usage within a chain (for example, AV-AJ, BV-BJ) and across chains (for example,
AV-BV, AV-BJ), and to quantify gene preference usage (the quantification was done by com-
paring the gene frequencies in our epitope-specific repertoires to those seen in a background
set of publicly available non-epitope-selected repertoire using the Shannon diversity index).
The analysis was done by combining productive single-cell TCRαβ sequences from the 4
donors at each time point and for each epitope. A total of 65 and 64 (YVL-BR; AIM and
CONV) and 48–52 (GLC-BM; AIM and CONV) productive paired TCRαβ sequences were
generated.
EBV DNA quantitation in B cells
B cells were purified from whole blood using the RosetteSep human B-cell enrichment cocktail
according to the manufacturer’s recommendations (StemCell Technologies, Vancouver BC,
Canada). Cellular DNA was extracted using QIAGEN DNeasy Blood & Tissue Kit (Valencia,
CA). Each DNA sample was diluted to 5ng/ul and the Roche LightCycler EBV Quantitation
Kit (Roche Diagnostics, Indianapolis, IN) was used to quantify EBV DNA copy number in the
samples as recommended by the manufacturer. Reactions were run in duplicate. B cell counts
in each sample were determined using a previously described PCR assay to quantify the copy
number of the gene encoding CCR5 (two copies per diploid cell) [53]. Samples were normal-
ized to B cell counts and EBV DNA copy number was calculated as DNA copy per 106 B cells.
TCR cloning
Full-length TCRα and TCRβ chains were amplified using the synthesized cDNA (described
above) as template, a forward primer (specific to the corresponding Vα or Vβ gene segment
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identified by single-cell CDR3 sequencing) and a reverse primer specific to the constant
region. The alpha chain was linked to the beta chain via the viral P2A sequence for stoichio-
metric expression and subcloned by homologous recombination into the pscALPS lentiviral
vector (a gift from Dr. Jeremy Luban).
Lentivirus transduction of TCR
293T cells (CRL-3216, ATCC) and J76 cells (a TCR-deficient CD8α-expressing Jurkat cell line
[54]; a gift from Dr. Wolfgang Uckert) were maintained in DMEM and RPMI, respectively,
containing 10% FBS, HEPES and L-glutamine. Viral packaging was performed in 293T cells
using the following three vectors (gifts from Dr. Jeremy Luban): recombinant lentiviral vector
containing the cloned TCR gene, an HIV-1 Gag-Pol packaging plasmid (psPAX2) and a
VSV-G plasmid (pMD2.G), and the Lipofectamine 2000 Transfection Reagent Kit (Invitrogen,
Carlsbad, CA) as recommended by the manufacturer. Infection was performed by incubating
the harvested virus supernatant with J76 cells. The cells were expanded and tetramer staining
of the TCR-transduced J76 cells was performed 5 days post infection to validate the specificity
of the overexpressed TCRs.
CD69 upregulation
T2 HLA-A2 expressing antigen-presenting cells (CRL-1992, ATCC) were maintained in RPMI
containing 10% FBS, HEPES and L-glutamine. T2 cells were pulsed with the desired peptide
concentration overnight at 37˚C. The cells were then washed to remove excess peptide. The
peptide-pulsed T2 cells were co-cultured with TCR-transduced J76 cells for 90 minutes. Cells
were harvested and stained with anti-CD8, anti-CD3 and anti-CD69 for 30 minutes in staining
buffer. Cells were washed twice and analyzed via flow cytometry using a Calibur (BD Biosci-
ences). Assay was performed in duplicate.
Soluble HLA-A2/YVL-BR protein production and crystallization
Soluble HLA-A2/YVL-BR complexes were prepared by folding urea-solubilized bacterially-
expressed inclusion bodies of HLA-A2 heavy chain and human βeta2-microglobulin in the
presence of 5mg/L synthetic YVL-BR peptide essentially as described [55], followed by concen-
tration and buffer exchange into 10mM Tris-Cl (pH 8.0) using a tangential flow concentrator.
Folded HLA-A2/peptide complexes were isolated from the buffer-exchanged folding mixture
by a series of chromatography steps consisting of Hitrap Q and Mono Q ion exchange and S-
200 gel-filtration columns (GE healthcare). Crystals were grown from purified HLA-A2/
YVL-BR by sitting drop vapor diffusion using 10.5% (w/v) PEG 4000, 35 mM Tris base/ HCl
(pH 8.5), 70 mM Li2SO4. Crystals were briefly soaked in 1:1 mixture of saturated sucrose and
reservoir buffer for cryoprotection and flash-frozen in liquid nitrogen and sent to LRL-CAT
beamline at the Advanced Photon Source (Argonne, IL USA).
HLA-A2/YVL-BR Structure determination and refinement
Diffraction data extending to ~ 3.2Å collected from a single crystal were integrated and
indexed using Mosflm [56]. Initially data were indexed in a C2 unit cell (189.2 x 49.7 x 291.6
Å, β = 94.5˚), with molecular replacement using Phaser [57] identifying four copies per asym-
metric unit of a HLA-A2 model [26] with TFZ = 22. However, refinement of this model stalled
at Rfree = 0.42. Re-examination of the diffraction pattern identified a lattice of weak spots
spaced between the stronger spots originally indexed (S4A Fig), and the data were reindexed
in a P21 unit cell (189.9 x 100.2 x 292.4 Å, β = 94.4˚). The newly identified spots comprise the
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k = 2n+1 and h+(k/2) = 2n+1 sets (S4 Fig). Additional molecular replacement, symmetry con-
siderations, and examination of composite-omit maps calculated using CCP4i [58] identified
20 copies of HLA-A2 per asymmetric unit (S4B Fig). The molecules are arranged in two layers
viewed looking into the ac plane (S4C Fig); slight differences can be observed between these
layers, and between similarly oriented molecules within the same layer (S4D Fig). These differ-
ences, along with four molecules (A,J,K,T) not identified in the C2 cell, explain the lower sym-
metry and strong translational pseudosymmetry that resulted in weak intensities for the k = 2n
+1 and h+(k/2) = 2n+1 spots. After identification of the correct crystallographic and non-crys-
tallographic symmetries, clear electron density covering all peptide atoms was observed in
20-fold averaged composite omit maps (S4E Fig), and a model for the YVL-BR peptide was
built using Coot [59]. Refinement using Phenix [60] proceeded smoothly despite the relatively
low resolution when dihedral restraints to a higher-resolution reference model were provided.
Models for the YVL-BR peptide, which was not included in the reference model restraints, did
not vary significantly between the non-crystallographically related copies (S4F Fig). A paired
refinement test [61] confirms 3.3 Å as a suitable resolution cutoff. Final refinement statistics,
shown in S3 Table are within the range of other structures determined at this resolution in the
Protein Data Bank. PyMOL (The PyMOL Molecular Graphics System, Version 2.0 Schro-
dinger, LLC) was used for graphical representation of molecular structures.
Supporting information
S1 Fig. Flow cytometry analysis of J76 cells transduced with WT or mutant K113A TCRs
and GFP, as a mock control, and stained with the cognate A2-YVL-BR (top) or an irrele-
vant A2-GLC-BM (bottom) tetramer and CD3 antibody. The CDR3α and β amino acid
sequences of the TCRs are shown. Bold: residue that has been mutated.
(PDF)
S2 Fig. The KD motif is partially non-germline and is encoded by different nucleotide
sequences (A & B). aa: amino acid; nt: nucleotide; bold: N nucleotide additions.
(PDF)
S3 Fig. Hierarchical clustering of GLC-BM-specific TCRα/β in AIM and CONV. TCRαβ
clustering along with corresponding TCR logos for GL-BM-specific CD8 T-cell responses in
AIM and CONV. Number on the branches and next to TCR logos depicts number of TCRs
contributing to the cluster. Color of the branches indicates the TCR probability generation
scores. The bar at the bottom of the CDR3 logo is color-coded by the source of the nucleotide.
Light grey, red, black, and dark grey denote that the nucleotides encoding those amino acid
residues originate from the V, N, D and J regions, respectively. Analyses are based on Dash
et al. [20].
(PDF)
S4 Fig. HLA-A2/YVL-BR structure determination and refinement. (A) Top, Representation
of the (h,k,0) plane, showing weak intensities in the k = 2n+1 layers (k has odd values, alternat-
ing horizontal rows) and the h+k/2 = 2n+1 layers (h has odd values in the lines where k is
even, alternating spots within the stronger horizontal rows). Bottom, average mean spot inten-
sities for various sets of diffraction spots. (B) Views of the P21 unit cell and asymmetric unit
with HLA-A2/YVL-BR molecules shown in different colored CPK models. (C) Ribbon dia-
gram showing orientation of HLA-A2/YVL-BR molecules within the asymmetric unit. (D)
Small rotational differences between some of the non-crystallographically related molecules
break the apparent C2 symmetry responsible for the strong set of diffraction spots, resulting in
the observed translational pseudosymmetry. (E) Composite omit 2Fo-Fc electron density in
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the vicinity of the VYL-BR peptide (blue bonds), with HLA-A2 shown in ribbon representa-
tion. (F) Overlay of 20 HLA-A2/YVL-BR models.
(PDF)
S1 Table. Characteristics of study population. 1Single-cell paired TCRαβ sequencing was
performed on tetramer sorted CD8 T cells of all four donors at presentation with AIM and 5–8
months later. 2Time elapsed between AIM and CONV. 3Frequency of HLA-A2 restricted GLC
or YVL tetramer+ cells within CD3+ CD8+ T cells in PBMCs isolated from each respective
donor. 4B cells were not available from this donor to perform a viral load assay. AIM: acute
infectious mononucleosis; CONV: convalescence; M: male; F: Female.
(DOCX)
S2 Table. Paired single-cell GLC-specific TCR amino acid sequences. 1Color-coded by
CDR3α clones. 2Color-coded by CDR3β clones.
(DOCX)
S3 Table. HLA-A2 / YVL data collection and refinement statistics.
(DOCX)
S4 Table. Paired single-cell epitope-specific TCR nucleotide sequences.
(XLSX)
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